top of page
Search Results

36 items found for "Christel Menet"

  • 📰 GPCR Weekly News, September 11 to 17, 2023

    Christel Menet, Dr. Ben Myers and Dr. Niña Caculitan. protein-coupled receptors and tumor microenvironment in melanoma Methods & Updates in GPCR Research Genetic Deadline September 27, 2023 GPCR Events, Meetings, and Webinars September 25 - 28, 2023 | Discovery On Closed November 15 - 17, 2023 | MPGPCR Conference November 20 - 23, 2023 | ASCEPT Annual Scientific Meeting 24 - 29, 2024 | Ligand Recognition and Molecular Gating Conference April 5 - 10, 2024 | AACR Annual Meeting

  • ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the...

    October 2022 ADGRL3 genomic variation implicated in neurogenesis and ADHD links functional effects to the incretin polypeptide GIP "Attention deficit/hyperactivity disorder (ADHD) is the most common childhood neurodevelopmental disorder. Single nucleotide polymorphisms (SNPs) in the Adhesion G Protein-Coupled Receptor L3 (ADGRL3) gene are associated with increased susceptibility to developing ADHD worldwide. However, the effect of ADGRL3 non-synonymous SNPs (nsSNPs) on the ADGRL3 protein function is vastly unknown. Using several bioinformatics tools to evaluate the impact of mutations, we found that nsSNPs rs35106420, rs61747658, and rs734644, previously reported to be associated and in linkage with ADHD in disparate populations from the world over, are predicted as pathogenic variants. Docking analysis of rs35106420, harbored in the ADGLR3-hormone receptor domain (HRM, a common extracellular domain of the secretin-like GPCRs family), showed that HRM interacts with the Glucose-dependent insulinotropic polypeptide (GIP), part of the incretin hormones family. GIP has been linked to the pathogenesis of diabetes mellitus, and our analyses suggest a potential link to ADHD. Overall, the comprehensive application of bioinformatics tools showed that functional mutations in the ADGLR3 gene disrupt the standard and wild ADGRL3 structure, most likely affecting its metabolic regulation. Further in vitro experiments are granted to evaluate these in silico predictions of the ADGRL3-GIP interaction and dissect the complexity underlying the development of ADHD." Read more at the source #DrGPCR #GPCR #IndustryNews

  • 2nd IRN i-GPCRnet, September 30 to October 1st, 2022. University of Wurzburg, Germany

    August 2022 "We are happy to announce you our 2nd IRN i-GPCRnet meeting that will be held at the University

  • Discovery On Target, October 17-20, 2022, Boston, USA

    August 2022 "Join Us in Boston for Discovery On Target 2022! Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules." Read more at the source #DrGPCR #GPCR #IndustryNews

  • 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry. October 5-7, 2022, Verona, Italy

    August 2022 "GPCRs in Medicinal Chemistry Event 8th RSC / SCI symposium on GPCRs in Medicinal Chemistry Dates Wednesday-Friday, 5th-7th October 2022 Place Evotec Campus Levi-Montalcini, Verona, Italy Downloads and Links Registration closing dates: 6th September – registration against invoice (bank transfers): Tuesday, 6th September 30th September – online registration (card payments)" Read more at the source #DrGPCR #GPCR #IndustryNews

  • 4GPCRnet, September 26-29, 2022. Leipzig, Germany

    August 2022 "WELCOME 4GPCRnet meeting bringing together four of the biggest GPCR networks in Europe for a joint meeting in Leipzig. Rise and ERNEST plus DFG-funded SFB1423 and FOR2372) have joined forces to organize an international meeting

  • Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research

    December 2021 "Meet Peter McNamara, Ph.D., Tectonic’s SVP, Head of Research.

  • From DNA day to GPCR genomics

    It provided a fundamental understanding of how genetic information is stored and transferred between association studies and next-generation sequencing, have enabled the uncovering of associations between GPCR genetic The genetic variation in GPCRs is extensive; databases like GPCRdb provide a large database of genetic

  • 📰 GPCR Weekly News, July 10 to 16, 2023

    GPCRs in Cardiology, Endocrinology, and Taste Clinical, Pathophysiologic, Genetic, and Therapeutic Progress Webinar Presentation for Q2 FY2023 Financial Results Neurocrine Biosciences Announces Appointment of Christine Ververken, will join WuXi AppTec's upcoming online series "BOLD: Innovation That Matters" GPCR Events, Meetings NEW Discovery On Target (September 25 - 28, 2023) 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27,

  • In vivo detection of GPCR-dependent signaling using fiber photometry and FRET-based biosensors

    August 2022 "Genetically encoded fluorescent biosensors allow intracellular signaling dynamics to be described in detail here, uses adeno-associated viruses infused intracerebrally in order to express genetically-encoded

  • The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1

    Genetic variants in ITGA9, which encodes the α9 subunit of integrin α9β1, and SVEP1, a ligand for integrin

  • GRK3 is a poor prognosticator and serves as a therapeutic target in advanced gastric adenocarcinoma

    Through genetic and pharmacologic modulations of GRK3, a series of functional and molecular studies were

  • Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals

    the endogenous dopaminergic circuits have limited specificity, reversibility, resolution, or require genetic

  • 📰 GPCR Weekly News, March 18 to 24, 2024

    Thompson, Alexander Hauser, Caroline Gorvin et al. for their research on GPCR gene variants and human genetic other organelles Reviews, GPCRs, and more G protein-coupled receptor (GPCR) gene variants and human genetic Primary And All Secondary Endpoints In The Phase 3 Pathfndr-2 Study In Acromegaly Patients GPCR Events, Meetings Discovery Chemistry April 4 - 7, 2024 | American Physiology Summit April 5 - 10, 2024 | AACR Annual Meeting

  • Primary cilia and SHH signaling impairments in human and mouse models of Parkinson’s disease

    September 2022 "Parkinson’s disease (PD) as a progressive neurodegenerative disorder arises from multiple genetic

  • Verily links up with Sosei Heptares for GPCR drug discovery

    the vast potential for GPCR-targeting drugs in treating a range of health conditions, from cancer and genetic

  • Sweet taste receptor agonists attenuate macrophage IL‐1β expression and eosinophilic inflammation...

    The mechanisms underlying their anti‐inflammatory effects were assessed using specific inhibitor, genetic

  • Although the cannabinoid type-2 receptor (CB2) is highly expressed in the immune system, emerging...

    The development of new CB2-related pharmacological and genetic tools, including the first small molecule

  • Latrophilin-1 drives neuron morphogenesis and shapes chemo- and mechanosensation-dependent ...

    expression and RNA-Seq analyses revealed specific LAT-1-positive neurons and first insights into the genetic

  • Pharmacological targeting of cGAS/STING-YAP axis suppresses pathological angiogenesis and...

    cGAS expression was induced in fibrotic liver and kidney, but suppressed in endothelial cells. cGAS genetic

  • 📰 GPCR Weekly News, January 29 to February 4, 2024

    Methods & Updates in GPCR Research Engineering, applications, and future perspectives of GPCR-based genetically encoded fluorescent indicators for neuromodulators Illuminating the brain-genetically encoded single Tectonic Therapeutic Announce Merger Trevena Inc Elevates Barry Shin to Executive VP and CFO GPCR Events, Meetings , and Webinars February 11 - 14, 2024 | 2024 BPS Annual Meeting February 20, 2024 | Career Opportunities Discovery Chemistry April 4 - 7, 2024 | American Physiology Summit April 5 - 10, 2024 | AACR Annual Meeting

  • Rescue of Cell Surface Expression and Signaling of Mutant Follicle-Stimulating Hormone Receptors

    These findings aid in advancing the understanding of the effects of genetic mutations on GPCR function

  • 📰 GPCR Weekly News

    GPCRs in Oncology and Immunology Clinical, pathophysiologic, genetic and therapeutic progress in Primary Genetic Code Expansion To Enable Site-Specific Bioorthogonal Labeling of Functional G Protein-Coupled GPCR Events, Meetings, and Webinars 2nd GPCR-Targeted Drug Discovery Summit | February 21-23, Boston. GEM2023 (14-17 March 2023). 8th and final ERNEST Meeting May 3-7, 2023 in Crete.

  • 📰 GPCR Weekly News, June 12 to 18, 2023

    Methods & Updates in GPCR Research Spatiotemporal GPCR signaling illuminated by genetically encoded fluorescent GmbH Revolutionizes Metabolic Disorder Treatments Structure Therapeutics listed on Nasdaq GPCR Events, Meetings , and Webinars NEW FREE ERNEST ECI zoominar (June 22, 2023) NEW Meet Inoviem Scientific Team (June 19 (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Retreat (November 2

  • Synaptic integration of subquantal neurotransmission by co-localized G protein coupled receptors in

    This reduction in cleft glutamate concentration was confirmed by imaging glutamate release using a genetic

  • 📰 GPCR Weekly News, February 27 to March 5, 2023

    Structural details of a Class B GPCR-arrestin complex revealed by genetically encoded crosslinkers in GPCR Events, Meetings, and Webinars ERNEST ECI zoominar. (March 9) GEM2023. (March 14-17, 2023). (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) 8th and final ERNEST Meeting in Crete. (May 3 - 7, 2023). (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs PhD candidate

  • 📰 GPCR Weekly News, April 24 to 30, 2023

    Genetic variants of G-protein coupled receptors associated with pubertal disorders. Candidates Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors GPCR Events, Meetings (May 22 - 26, 2023) 2nd LEAPS Meets Life Sciences Conference. (May 14 - 19, 2023) NEW PEGS Boston (May 15 - 19, 2023) 8th and final ERNEST Meeting in Crete. (July 2 - 7, 2023). 3rd Annual Meeting IRN I-GPCRNet (October 25 - 27, 2023) GPCR Jobs NEW Associate

bottom of page